NEW YORK (GenomeWeb) – Integrated Diagnostics said today that Medicare contractor Palmetto GBA has issued a draft local coverage determination proposing coverage of its Xpresys Lung 2 lung cancer test.

The company also announced that it has raised $6.1 million in Series C funding from Baird Capital and InterWest Partners.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.